Co-targeting mTOR and YAP signaling in glioblastoma

胶质母细胞瘤中 mTOR 和 YAP 信号的共同靶向

基本信息

项目摘要

Project Summary Glioblastomas are the most common primary malignancy of the central nervous system and are typically rapidly proliferating tumors resistant to chemotherapeutic intervention. Their complex and heterogeneous nature has hampered progress towards the development of successful therapies. The mammalian target of rapamycin (mTOR) kinase and the YAP oncoprotein have recently emerged as an attractive targets for therapeutic intervention in glioblastoma. Two multisubunit complexes containing mTOR exist, mTORC1 and mTORC2 which differ in their regulatory subunit compositions containing Raptor and Rictor, respectively. While hyperactive mTORC1 activity has been targeted in many cancers, including glioblastoma with limited success, dysregulated mTORC2 function has only recently begun to be investigated. The downstream effector of the Hippo cascade, YAP has been found to be overexpressed in brain cancers and recently, experimental evidence has supported crosstalk mechanisms coordinating the activities of these cascades to promote glioblastoma proliferation, motility and invasiveness. In this application we propose to 1). identify and characterize glioblastoma-associated activating mutations in YAP which render this oncoprotein constitutively active, 2). clarify recently identified signaling crosstalk interactions between mTORC2 and Hippo signaling cascade components and 3.) evaluate a novel YAP-TEAD specific small molecule inhibitor alone and in combination with mTORC2 specific inhibitors in xenografts and genetically engineered mouse (GEM) models of the disease. We also propose to investigate and chemically modify the YAP inhibitor to build in desired anti-glioblastoma effects.
项目总结

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Function of Deptor and its roles in hematological malignancies.
  • DOI:
    10.18632/aging.202462
  • 发表时间:
    2021-01-07
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Morales-Martinez M;Lichtenstein A;Vega MI
  • 通讯作者:
    Vega MI
Turnover of the mTOR inhibitor, DEPTOR, and downstream AKT phosphorylation in multiple myeloma cells, is dependent on ERK1-mediated phosphorylation.
  • DOI:
    10.1016/j.jbc.2022.101750
  • 发表时间:
    2022-04
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Vega M;Chen Y;Shi Y;Gera J;Lichtenstein A
  • 通讯作者:
    Lichtenstein A
Targeting the YAP-TEAD interaction interface for therapeutic intervention in glioblastoma.
  • DOI:
    10.1007/s11060-021-03699-6
  • 发表时间:
    2021-04
  • 期刊:
  • 影响因子:
    3.9
  • 作者:
    Saunders JT;Holmes B;Benavides-Serrato A;Kumar S;Nishimura RN;Gera J
  • 通讯作者:
    Gera J
Translation of circHGF RNA encodes an HGF protein variant promoting glioblastoma growth through stimulation of c-MET.
  • DOI:
    10.1007/s11060-023-04331-5
  • 发表时间:
    2023-05
  • 期刊:
  • 影响因子:
    3.9
  • 作者:
    Saunders, Jacquelyn T. T.;Kumar, Sunil;Benavides-Serrato, Angelica;Holmes, Brent;Benavides, Kennedy E. E.;Bashir, Muhammad T. T.;Nishimura, Robert N. N.;Gera, Joseph
  • 通讯作者:
    Gera, Joseph
mTORC2-mediated direct phosphorylation regulates YAP activity promoting glioblastoma growth and invasive characteristics.
  • DOI:
    10.1016/j.neo.2021.07.005
  • 发表时间:
    2021-09
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Holmes B;Benavides-Serrato A;Saunders JT;Kumar S;Nishimura RN;Gera J
  • 通讯作者:
    Gera J
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOSEPH F GERA其他文献

JOSEPH F GERA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOSEPH F GERA', 18)}}的其他基金

Co-targeting mTOR and YAP signaling in glioblastoma
胶质母细胞瘤中 mTOR 和 YAP 信号的共同靶向
  • 批准号:
    9889911
  • 财政年份:
    2018
  • 资助金额:
    $ 32.01万
  • 项目类别:
Mechanisms of Resistance to mTOR-Targeted Therapies
mTOR 靶向治疗的耐药机制
  • 批准号:
    9339574
  • 财政年份:
    2014
  • 资助金额:
    $ 32.01万
  • 项目类别:
Mechanisms of Resistance to mTOR-Targeted Therapies
mTOR 靶向治疗的耐药机制
  • 批准号:
    8907659
  • 财政年份:
    2014
  • 资助金额:
    $ 32.01万
  • 项目类别:
Mechanisms of Resistance to mTOR-Targeted Therapies
mTOR 靶向治疗的耐药机制
  • 批准号:
    8735575
  • 财政年份:
    2014
  • 资助金额:
    $ 32.01万
  • 项目类别:
Mechanisms of Resistance to mTOR Targeted Therapies
mTOR 靶向治疗的耐药机制
  • 批准号:
    10266024
  • 财政年份:
    2014
  • 资助金额:
    $ 32.01万
  • 项目类别:
Mechanisms of Resistance to mTOR-Targeted Therapies
mTOR 靶向治疗的耐药机制
  • 批准号:
    8974387
  • 财政年份:
    2014
  • 资助金额:
    $ 32.01万
  • 项目类别:
Mechanisms of Resistance to mTOR Targeted Therapies
mTOR 靶向治疗的耐药机制
  • 批准号:
    10579603
  • 财政年份:
    2014
  • 资助金额:
    $ 32.01万
  • 项目类别:
Dysregulation of mTORC2 in gliomas
胶质瘤中 mTORC2 的失调
  • 批准号:
    8341292
  • 财政年份:
    2012
  • 资助金额:
    $ 32.01万
  • 项目类别:
Dysregulation of mTORC2 in gliomas
胶质瘤中 mTORC2 的失调
  • 批准号:
    8658059
  • 财政年份:
    2012
  • 资助金额:
    $ 32.01万
  • 项目类别:
Dysregulation of mTORC2 in gliomas
胶质瘤中 mTORC2 的失调
  • 批准号:
    8512676
  • 财政年份:
    2012
  • 资助金额:
    $ 32.01万
  • 项目类别:

相似海外基金

How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.01万
  • 项目类别:
    Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 32.01万
  • 项目类别:
    Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 32.01万
  • 项目类别:
    Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.01万
  • 项目类别:
    Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 32.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 32.01万
  • 项目类别:
    Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 32.01万
  • 项目类别:
    Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 32.01万
  • 项目类别:
    Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
  • 批准号:
    23K00129
  • 财政年份:
    2023
  • 资助金额:
    $ 32.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
  • 批准号:
    2883985
  • 财政年份:
    2023
  • 资助金额:
    $ 32.01万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了